{"result": {"id": "0407dc83-b6ce-4e70-9b1e-fad308466ef7", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>SBP<|>EVENT<|>Systolic blood pressure (SBP) is a key measurement in hypertension diagnosis and risk stratification\")\n##\n(\"entity\"<|>DBP<|>EVENT<|>Diastolic blood pressure (DBP) is a key measurement in hypertension diagnosis and risk stratification\")\n##\n(\"entity\"<|>CKD 3 STAGE<|>EVENT<|>Chronic kidney disease stage 3 with estimated glomerular filtration rate 30-59 ml/min/1.73m²\")\n##\n(\"entity\"<|>CKD 4 STAGE<|>EVENT<|>Chronic kidney disease stage 4 with estimated glomerular filtration rate 15-29 ml/min/1.73m²\")\n##\n(\"entity\"<|>TARGET ORGAN DAMAGE<|>EVENT<|>Organ damage caused by long-term hypertension including heart, kidney, brain and vascular systems\")\n##\n(\"entity\"<|>ANTIHYPERTENSIVE DRUGS<|>EVENT<|>Medications used to treat hypertension including long-acting and combination formulations\")\n##\n(\"relationship\"<|>SBP<|>HYPERTENSION<|>Systolic blood pressure is a primary diagnostic criterion for hypertension<|>9)\n##\n(\"relationship\"<|>DBP<|>HYPERTENSION<|>Diastolic blood pressure is a primary diagnostic criterion for hypertension<|>9)\n##\n(\"relationship\"<|>CKD 3 STAGE<|>CHRONIC KIDNEY DISEASE<|>Stage 3 is a defined progression level of chronic kidney disease<|>8)\n##\n(\"relationship\"<|>CKD 4 STAGE<|>CHRONIC KIDNEY DISEASE<|>Stage 4 is a severe progression level of chronic kidney disease<|>8)\n##\n(\"relationship\"<|>TARGET ORGAN DAMAGE<|>HYPERTENSION<|>Long-term hypertension causes damage to multiple organ systems<|>8)\n##\n(\"relationship\"<|>ANTIHYPERTENSIVE DRUGS<|>HYPERTENSION<|>These medications are specifically used to control hypertension<|>9)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752166351, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 481, "prompt_tokens": 2770, "total_tokens": 3251, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2688}, "prompt_cache_hit_tokens": 2688, "prompt_cache_miss_tokens": 82}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 降压药物：优先推荐可 以维持24h的长效降压药物。如使 用中、短效制剂，则需每天2~3次给 药，以达到平稳控制血压1,12- 16。\n　　　(3)联合治疗：对SBP≥160mmHg   和/或DBP≥100  mmHg、高危患者和 单药治疗未达标的高血压患者应进 行联合降压治疗，包括自由联合或 单片复方制剂。对SBP≥140  mmHg 和/或DBP≥90  mmHg的中危患者，从\n依从性考虑，固定复方制剂有更好 的适应性；为早期达标，在保证患者 安全情况下也可起始联合治疗17]。\n　　　(4)个体化治疗：根据患者合并 症的不同和药物疗效及耐受性，以 及患者个人意愿或长期承受能力， 选择适合患者个体的降压药物。\n　　　(5)药物经济学：高血压需终生 治疗，需要考虑成本/效益。\n　　　2.治疗药物的选择：根据适应证 选择降压药物，临床常用药物和指 征见表5[1-2]。\n　　　3.联合治疗：联合应用降压药物 已成为降压治疗的基本方法18。为  了达到目标血压水平，大部分高血压  患者需要使用2种或以上降压药物。 高血压联合治疗方案见图2。\n\n　　　　　　　　　　　　　　　　　　　　　　　　　\n\n\n·726·                                                                                                                    中华全科医师杂志2019年8月第18卷第8期Chin JGen Pract,August 2019,Vol.18,No.8\n\n表3                                           血压升高患者心血     管风险水平分层\n\n\n其他心血管危险因素和疾病史\t血压(mmHg)\n\tSBP 130~139和/或 DBP 85~89\tSBP 140~159和/或 DBP90~99\tSBP 160~179和/或 DBP 100~109\tSBP≥180和/或 DBP≥110\n无\t\t低危\t中危\t高危\n1~2个其他危险因素\t低危\t中危\t中/高危\t很高危\n≥3个其他危险因素，靶器官损害，或CKD 3期， 无并发症的糖尿病\t中/高危\t高危\t高危\t很高危\n临床并发症，或CKD≥4期，有并发症的糖尿病\t高/很高危\t很高危\t很高危\t很高危\n　　注 ：CKD慢性肾脏疾病；SBP 收缩压；DBP舒张压；CKD3 期估算的肾小球滤过率30~59ml·min1·(1.73m2)-1;CKD       4期估算的肾小球滤 过率15~29ml·min-1·(1.73m2)-1;-      无；1mmHg=0.133kPa\n表4影响高血压患者心血管预后的重要因素\n心血管危险因素\t靶器官损害\t伴发临床疾病\n· 高血压(1~3级)\n· 男性>55岁；女性>65岁\n· 吸烟或被动吸烟\n· 糖耐量受损\n餐后2h血糖7.8~11.0 mmol/L和/或 空腹血糖异常(6.1~6.9mmol/L)\n· 血脂异常\nTC≥5.2\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>CHRONIC KIDNEY DISEASE<|>EVENT<|>Chronic kidney disease is a condition that affects kidney function and is a risk factor for cardiovascular disease in hypertensive patients\")\n##\n(\"entity\"<|>CARDIOVASCULAR DISEASE<|>EVENT<|>Cardiovascular disease is a potential complication of hypertension and is influenced by various risk factors\")\n##\n(\"entity\"<|>HYPERTENSION<|>EVENT<|>Hypertension is a chronic condition requiring lifelong treatment and management to prevent complications\")\n##\n(\"relationship\"<|>HYPERTENSION<|>CARDIOVASCULAR DISEASE<|>Hypertension is a major risk factor for cardiovascular disease<|>8)\n##\n(\"relationship\"<|>HYPERTENSION<|>CHRONIC KIDNEY DISEASE<|>Hypertension can lead to or exacerbate chronic kidney disease<|>7)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_f478bbb37ee1f58c40518bf219fd8a9916fbf4eddc3365b3ecabf7c0a69a15ca_v2"}